1. Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/;2020.
2. National Academies of Sciences E, Medicine. Medications for Opioid Use Disorder Save Lives. Washington: The National Academies Press; 2019.
3. Dooling BCE, Stanley L. Extending Pandemic Flexibilities for Opioid Use Disorder Treatment: Telemedicine & Initiating Buprenorphine Treatment. 2021; https://regulatorystudies.columbian.gwu.edu/extending-pandemic-flexibilities-opioid-use-disorder-treatment. Accessed May 11, 2021.
4. Uscher-Pines L, Huskamp HA, Mehrotra A. Treating Patients With Opioid Use Disorder in Their Homes: An Emerging Treatment Model. JAMA. 2020;324(1):39-40.
5. Davis CS. The SUPPORT for Patients and Communities Act - What Will It Mean for the Opioid-Overdose Crisis? N Engl J Med. 2019;380(1):3-5.